Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
Not Applicable
Recruiting
- Conditions
- Acne
- Interventions
- Drug: Topical Antioxidant SerumDevice: AviClear Laser
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 10
- Registration Number
- NCT06376110
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Trial Evaluating Both Tolerability and Improvement for Signs of Facial Photoaging, Discoloration, and Texture in Adult Females of All Skin Types by Combining a Placebo Moisturizer and Non-ablative Laser.
Phase 4
Completed
- Conditions
- Photoaging
- Interventions
- Device: LaseMD LaserDevice: Sciton LaserDrug: Phyto A+ Brightening Treatment
- First Posted Date
- 2023-10-19
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 38
- Registration Number
- NCT06090071
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.
Phase 4
Completed
- Conditions
- Cutis Laxa FacialisXeroderma
- Interventions
- Device: HydraFacial Syndeo SystemDrug: ReGen-GFDevice: HydraFacial Elite MD System
- First Posted Date
- 2023-07-06
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 27
- Registration Number
- NCT05932732
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults
Not Applicable
Completed
- Conditions
- Photodamaged Skin
- Interventions
- Drug: Vitamin C with AHA Exfoliative SerumDrug: Placebo serum
- First Posted Date
- 2023-06-18
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 34
- Registration Number
- NCT05908825
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults
Phase 2
Completed
- Conditions
- Superficial Basal Cell Carcinoma
- Interventions
- First Posted Date
- 2023-02-06
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 5
- Registration Number
- NCT05713760
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults
Phase 3
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: CeraVe, Topical Cream
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Austin Institute for Clinical Research
- Target Recruit Count
- 21
- Registration Number
- NCT05203315
- Locations
- 🇺🇸
Austin Institute for Clinical Research, Inc., Pflugerville, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath